Renal lesions in von Hippel-Lindau disease: Immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins

Histopathology

Volumn 36, Issue 5, 2000, Pages 457-465

  Paraf, F ^a,b   Chauveau, D ^a   Chretien Y ^a   Richard, S ^a   Grunfeld J P ^a   Droz, D ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Adhesion molecules; Immunohistochemistry; Renal cell carcinoma; Renal cysts; Renal tubular markers; von Hippel Lindau disease

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; CYTOSKELETON PROTEIN; INTEGRIN; LECTIN;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; NEPHRON; PRIORITY JOURNAL; PROTEIN EXPRESSION; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; APOPTOSIS; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DNA, NEOPLASM; FEMALE; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRINS; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; KIDNEY TUBULES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034030085     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00857.x     Document Type: Article

References (35)

1. 1. Maher ER, Kaelin WGJ. von Hippel-Lindau disease. Medicine (Baltimore) 1997; 76; 381-391.
2. 2. Latif F, Tory K, Gnarra J et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260; 1317-1320.
3. 3. Richard S, Chauveau D, Chrétien Y et al. Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Adv. Nephrol. 1994; 23; 1-27.
4. 4. Neumann HPH, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int. 1997; 51; 16-26.
5. 5. Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum. Pathol. 1988; 19; 1072-1079.
6. 6. Choyke PL, Glenn GM, Walther M et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR 1992; 159; 1229-1234.
7. 7. Chauveau D, Duvic C, Chrétien Y et al. Renal involvement in von Hippel-Lindau disease. Kidney Int. 1996; 50; 944-951.
8. 8. Poston CD, Jaffe GS, Lubensky IA et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. J. Urol. 1995; 153; 22-26.
9. 9. Thoenes W, Störkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract. 1986; 181; 125-143.
10. 10. Störkel S, Eble JN, Adlakha K et al. Classification of renal cell carcinoma: Workgroup no. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80; 987-989.
11. 11. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol 1982; 6; 655-663.
12. 12. Droz D, Zachar D, Charbit L, Gogusev J, Chrétien Y, Iris L. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am. J. Pathol. 1990; 137; 895-905.
13. 13. Kragel PJ, Walther MM, Pestaner JP, Filling-Katz MR. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients. Mod. Pathol. 1991; 4; 210-214.
14. 14. Droz D, Patey N, Paraf F, Chrétien Y, Gogusev J. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab. Invest. 1994; 71; 710-718.
15. 15. Gogusev J, Fournet JC, Couturier J et al. Renal cell carcinoma: recent progress. Adv. Nephrol. 1994; 23; 71-90.
16. 16. Patey N, Halbwachs-Mecarelli L, Droz D, Lesavre P, Noel LH. Distribution of integrin subunits in normal human kidney. Cell Adhes. Commun. 1994; 2; 159-167.
17. 17. Nelson JB, Oyasu R, Dalton DP. The clinical and pathological manifestations of renal tumors in von Hippel-Lindau disease. J. Urol. 1994; 152; 2221-2226.
18. 18. Ibrahim RE, Weinberg DS, Weidner N. Atypical cysts and carcinomas of the kidneys in the phacomatoses. A quantitative DNA study using static and flow cytometry. Cancer 1989; 63; 148-157.
19. 19. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J. Urol. 1995; 154; 2010-2014.
20. 20. Murphy WM, Beckwith JB, Farrow GM. Tumors of the Kidney, Bladder and Related Urinary Structures. Atlas of Tumor Pathology, third series. Washington DC: Armed Forces Institute of Pathology, 1994.
21. 21. Pitz S, Moll R, Störkel S, Thoenes W. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest 1987; 56; 642-653.
22. 22. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease. Am. J. Surg. Pathol 1994; 18; 1254-1260.
23. 23. Jongeneel CV, Quackenbush EJ, Ronco P, Verroust P, Carrel S, Letarte M. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity. J. Clin. Invest 1989; 83; 713-717.
24. 24. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74; 777-779.
25. 25. Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342; 705-708.
26. 26. Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum. Pathol. 1994; 25; 789-796.
27. 27. Paraf F, Gogusev J, Chrétien Y, Droz D. Expression of the oncoprotein bcl-2 in renal cells tumours. J. Pathol. 1995; 177; 247-252.
28. 28. Todd D, Yang G, Brown RW et al. Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors. Hum. Pathol. 1996; 27; 1012-1017.
29. 29. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K. Prognostic value of Ki-67 expression in renal cell carcinomas. Eur. Urol. 1997; 31; 350-355.
30. 30. Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. Am. J. Pathol. 1996; 149; 2089-2094.
31. 31. Rouquette I, Delisle MB, Cervera P, Richard S, Uro E, Rumeau JL. Adénocarcinome papillaire de bas grade du sac endolymphatique. A propos de trois observations avec étude immunohistochimique. Ann. Pathol. 1996; 16; 271-275.
32. 32. Gilcrease MZ, Schmidt L, Zbar B, Truong L, Rutledge M, Wheeler TM. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum. Pathol. 1995; 26; 1341-1346.
33. 33. Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marme D. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 1996; 56; 2299-2301.
34. 34. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 1995; 55; 1358-1364.
35. 35. Levy AP, Levy NS, Iliopoulos O, Jiang C, Kaelin WG Jr, Goldberg MA. Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int. 1997; 51; 575-578.